The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients
Clinical and Translational Oncology Aug 14, 2017
Guler OC, et al. – For the treatment of oligometastatic prostate cancer, 68Ga–PSMA–HBED–CC (68Ga–PSMA) PET–CT–guided RT was explored for its efficacy and toxicity. For this group of patients, 68Ga PSMA PET–CT–guided RT appeared as an attractive treatment strategy, providing optimal LC, low toxicity and a promising PFS in castration sensitive (CS) patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
